This podcast episode explores the relationship between innovation, risk, and unexpected shifts in the tech and health industries. It starts with a discussion on Amazon’s return-to-office policy and its impact on Seattle's traffic, then moves into a touching look at Luminate's chemo helmet designed for cancer patients. The episode also examines Flink's bold strategy in the unpredictable quick commerce market, highlighting the possibility of failure reminiscent of past efforts. It wraps up with TuSimple's surprising pivot from self-driving technology to AI animation, raising important questions about corporate governance and market sustainability.
Sign in to continue reading, translating and more.
Continue